Boston Therapeutics Inc.Boston Therapeutics, Inc. • March 2nd, 2016 • Pharmaceutical preparations
Reference is hereby made to the SPA. By executing this letter, the undersigned investor agrees that the offering amount shall be increased from $1,200,000 to $1,450,000. Accordingly, it is hereby agreed to by the parties that Section 1(d) of the Agreement shall be amended and restated to state the following:
